Načítá se...
Possibilities of optimization of the second line targeted therapy for metastatic renal cell carcinoma
Optimization of treatment of metastatic renal cell carcinoma (mRCC) is an important problem of modern oncological urology. Targeted drugs replaced immunotherapy with cytokines and became the new standard of treatment. Their introduction resulted in increased patients» lifespan and fundamentally chan...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
ABV-press
2017-09-01
|
| Edice: | Onkourologiâ |
| Témata: | |
| On-line přístup: | https://oncourology.abvpress.ru/oncur/article/view/719 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|